Neurology News

On June 28, the U.S. Supreme Court ruled 6-3 in Loper Bright Enterprises v. Raimondo, Secretary of Commerce to overturn a decades-old decision known as the “Chevron deference.”

PHILADELPHIA — In this Healio Video Perspective, Suzanne E. Schindler, MD, PhD, revealed phosphorylated tau biomarker assays were most accurate in identifying amyloid positron emission tomography status in Alzheimer’s disease.

The FDA has cleared an investigational new drug application for a phase 1 clinical trial evaluating a universal, allogenic cell therapy platform intended to treat progressive MS.

The FDA approved vorasidenib for certain patients with astrocytoma or oligodendroglioma.

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, discusses the results of the FIREFLY-1 (NCT04775485) trial she presented at International Symposium on Pediatric Neuro-Oncology.

An eight-item questionnaire, called Central Aspects of Pain, reliably measures nociplastic pain across a variety of chronically painful musculoskeletal conditions, according to data published in Rheumatology.

PHILADELPHIA — An analysis of more than 15 million Americans enrolled in Medicare found that those enrolled in the Medicare Advantage plan had a 4% lower dementia diagnosis rate than those in traditional Medicare, according to a presenter.

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, highlights keynote addresses from International Symposium on Pediatric Neuro-Oncology.

PHILADELPHIA — Consuming a high-sugar diet over 10 days was associated with memory issues as well as negative cardiometabolic health compared with a low-sugar diet, according to a poster presentation.

Older adults with diabetes who spend less time within their individualized HbA1c target range have a higher risk for developing Alzheimer’s disease and dementias, according to findings published in JAMA Network Open.